SUMMARY. Effects of hyaluronidase on myocardial water content and distribution, and on coronary vascular hemodynamics and endothelial cell transport function were assessed in isolated rabbit hearts during 3.5 hours of reperfusion after 30 minutes of global, no-flow ischemia. In nonischemic control hearts, perfusion pressure, left ventricular end-diastolic pressure, maximum +dP/dt, and intravascular clearance of radiolabeled albumin remained constant during 5 hours of continuous perfusion, while the mean-transit time and vascular into extravascular space clearance of radiolabeled albumin increased 1.5X and 2.5X baseline, respectively. During reperfusion after 30 minutes of no flow, perfusion pressure increased 53% and interstitial fluid volume increased 2-fold, while left ventricular end-diastolic pressure and maximum +dP/dt returned to control levels. The rate of intravascular clearance of radiolabeled albumin decreased 38%, and the mean-transit time and vascular-into-extravascular space clearance of albumin increased ~3x and 5x baseline, respectively. Hyaluronidase blocked the ischemia-reperfusion-induced increases in total water content and in interstitial fluid volume and reduced the increases in perfusion pressure and mean-transit time of radiolabeled albumin by 40% and 45%, respectively, but did not prevent the increase in albumin vascular-into-extravascular space clearance and the decrease in albumin clearance from the coronary vasculature. These findings indicate that hyaluionidase does not prevent ischemia-reperfusion-induced increases in albumin permeation of the coronary vasculature, and suggest that its protective effect on ischemic myocardium is mediated, instead, by reducing interstitial edema and vascular resistance. (Circ Res 56: [839][840][841][842][843][844][845][846][847][848][849][850] 1985) 
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SUMMARY. Effects of hyaluronidase on myocardial water content and distribution, and on coronary vascular hemodynamics and endothelial cell transport function were assessed in isolated rabbit hearts during 3.5 hours of reperfusion after 30 minutes of global, no-flow ischemia. In nonischemic control hearts, perfusion pressure, left ventricular end-diastolic pressure, maximum +dP/dt, and intravascular clearance of radiolabeled albumin remained constant during 5 hours of continuous perfusion, while the mean-transit time and vascular into extravascular space clearance of radiolabeled albumin increased 1.5X and 2.5X baseline, respectively. During reperfusion after 30 minutes of no flow, perfusion pressure increased 53% and interstitial fluid volume increased 2-fold, while left ventricular end-diastolic pressure and maximum +dP/dt returned to control levels. The rate of intravascular clearance of radiolabeled albumin decreased 38%, and the mean-transit time and vascular-into-extravascular space clearance of albumin increased ~3x and 5x baseline, respectively. Hyaluronidase blocked the ischemia-reperfusion-induced increases in total water content and in interstitial fluid volume and reduced the increases in perfusion pressure and mean-transit time of radiolabeled albumin by 40% and 45%, respectively, but did not prevent the increase in albumin vascular-into-extravascular space clearance and the decrease in albumin clearance from the coronary vasculature. These findings indicate that hyaluionidase does not prevent ischemia-reperfusion-induced increases in albumin permeation of the coronary vasculature, and suggest that its protective effect on ischemic myocardium is mediated, instead, by reducing interstitial edema and vascular resistance. (Circ Res 56: 839-850, 1985) WHEREAS hyaluronidase has been reported by some investigators (Maroko et al., 1972; Maclean et al., 1976; Hillis et al., 1977; Rovetto, 1977; Kloner et al., 1977; Ribeiro et al., 1978) to have a protective effect on ischemic myocardium, no beneficial effects have been observed by others (Most et al., 1976; Cairns et al., 1982) . Since hyaluronidase depolymerizes hyaluronic acid, a major mucopolysaccharide constituent of the cardiac interstitium, it has been postulated that this enzyme protects the heart by reducing tissue edema (de Oliveira and Levy, 1960) and by facilitating the diffusion of nutrients and metabolic waste products (Day, 1957) . It also has been shown that hyaluronidase decreases coronary vascular resistance (Rovetto, 1977; Overholser and Harris, 1981; SunnergTen and Rovetto, 1983) and increases collateral blood flow (Askenazi et al., 1977; Rovetto, 1977) . Thus, the improved metabolism of ischemic myocytes may be secondary to decreased interstitial edema and improved vascular hemodynamics. Since studies of the effect of hyaluronidase on vascular integrity have yielded conflicting results (Szabo and Magyar, 1958; Kloner et al., 1977 Kloner et al., , 1978 , we undertook the present study to examine further the effect of this enzyme on tissue water content and distribution, on vascular hemodynamics, and on endothelial cell functional integrity during reperfusion following 30 minutes of global, no-flow ischemia.
I-BSA in KH buffer, pH 7.0, was injected into the proximal aorta, and the single passage of this tracer through the coronary vasculature was monitored with external-detection equipment as described previously (Tilton et al., 1983) .
In selected experiments, Co-EDTA in KH buffer was perfused during the terminal 10 minutes. Hearts were removed, rinsed with saline, trimmed, blotted dry, weighed, and sectioned (6-8 transmural left ventricular sections) before assay of "Co radioactivity by 7-spectrometry. Perfusate radioactivity was assayed similarly. Selected transmural left ventricular sections were dried to constant weight at 70°C for determination of water content.
•y-Spectrometry Data Analysis
The 57 Co-EDTA volume of distribution per g wet weight (VEDTA) was calculated using
where C E DTA (heart) and CEDTA (perfusate) are, respectively, the specific 57 Co activities in each sample of heart (counts/min per g wet weight) and in perfusate (counts/ min per ml KH buffer). Results of tissue assays were converted into ml/g dry weight, and these data, together with baseline estimates of vascular volume derived from the two-compartment-model analysis of residue-detection data, were used to estimate the specific interstitial fluid volume, which also was used for the calculations of convective transport (Eqs. 10 and 12). We calculated intracellular water content (ml/g dry weight) at the end of each experiment by subtracting V E DTA (Eq. 1) from total water content determined gravimerrically.
Mathematical Model for Assessment of Radiolabeled Albumin Transport
The uptake and clearance of a bolus injection of 125 Ilabeled albumin in these heart preparations were interpreted with a two-compartment model describing temporal changes of radiolabeled tracer distributions due to transport of the label within the vasculature and between the vascular and extravascular spaces. Components of the model and complete mathematical derivations have been described previously (Tilton et al., 1983) , and only the principal equations used to interpret the experimental data are provided here. Conventional requirements are assumed to hold for the validity of tracer stimulus-response methods concerning stationarity and linearity (Perl, 1971) . Tracer movements are interpreted in terms of diffusive and convective transport mechanisms operating simultaneously within a hypothetical membrane (of assumed negligible tracer content) separating albumin-accessible vascular and extravascular spaces; no specific morphological identity is assigned to this membrane. The model parameters and their numerical estimates from the experimental data represent global averages. Spatial uniformity of detection efficiency is assumed.
With the use of a parameter-estimation technique described below, the biexponential function
is fitted to the experimental residue count-rate data. Here, t represents time elapsed after the instant the maximum count rate is observed after injection of the radiotracer bolus. The symbols Ai, A 2 , «i, and « 2 represent adjustable parameters and are related to the compartmental turnoverrate constants of the model, km, k ]2 and k 2) according to 
(3b)
where r 0 = r(t = 0), i.e., the peak count rate, whose instant of occurrence defines zero time. Parameter estimation was accomplished by utilizing an algorithm (Markham et al., 1976 ) based on maximum-likelihood estimation procedures for Poisson-distributed data (Sandor and Wilson, 1972; Snyder, 1973) , which was implemented by maximizing the Poisson-distribution likelihood function having the biexponential intensity specified by Equation 2. This provided estimates of A,, A 2 , «,, and « 2 of the intensity function, which were used in Equations 3-5, assuming stochastic independence of the variates, to obtain estimates of the turnover-rate constants. The k H in Equations 3-5 represent the fraction of the mass of tracer in compartment j that is transported, per unit time, into compartment i. Here, subscripts 1 and 2 denote, respectively, vascular space and extravascular space accessible to albumin; 0 denotes the surroundings external to both compartments 1 and 2. An interpretation of the compartmental turnover-rate constants of the model is based on the following equations, which relate them to perfusate flow, to the compartmental albumin spaces, and to the practical membrane transport coefficients (Kedem and Katchalsky, 1961; House, 1974; Perl, 1975) :
and
In the above, F is the measured specific perfusate flow, P is the surface area-averaged permeability coefficient, S is the total membrane surface available for permeation, J v is the net systemic fluid-filtration volume flow, a is the filtration-flowj-averaged solvent-drag reflection coefficient (Perl, 1975) /sec per g dry weight) (9) for the specific (i.e., weight-normalized) permeability coefficient surface-area product and
/sec per g dry weight) (10) for the specific ultrafiltration parameter, U. For the above, we further define the unidirectional clearances (Perl, 1975) and with F 21 & 7 l P S + 0 = k 21 V, 7 2 PS -U = k, 2 V 2 7 A 1/2(7, + 72).
Since V^ the specific extravascular space, is obtainable from the externally monitored radioalbumin count-rate history only in the special case when albumin ultrafiltration flux is zero, an independent estimate is required. For this reason, we report only the albumin forward unidirectional clearance, F 21 (Eq. 11), using baseline estimates of V,. In certain experiments (see Experimental Protocol), estimates of V 2 were determined from 37
Co-EDTA equilibrium data at the end of the perfusion. For these experiments, estimates of the specific permeability coefficient surface-area product and the specific ultrafiltration coefficient were obtained by evaluation of Equations 9 and 10. Approximate values of the thermodynamic activity coefficients for bovine serum albumin have been derived previously (Tilton et al., 1983) .
Thejnean of the distribution of radioalbumin transit times, tosA, is related to the parameters of the intensity function of the model, by (14) (A 2 /a 2 )]/r 0 as described previously (Tilton et al., 1983) .
Statistical Analysis
Within Runs
From initial estimates of variance for perfusate flow, heart dry weight, peak count rate (r 0 ), and the four parameters of the intensity function computed by the maximumlikelihood algorithm, variance estimates were computed for each of the derived physiological parameters using the theory of error propagation (Eadie et al., 1971) . Standard deviations were obtained as the positive square roots of the corresponding error propagation variances. Likewise, estimates of variance and standard deviation for tesA were obtained using error-propagation theory.
Between Runs
Means and standard deviations, as well as standard errors of the mean (for data presented graphically) were calculated for each parameter assessed for controls and ischemic groups at each perfusion time interval. A repeated-measures analysis of variance test (based on data obtained during the last 2 hours of reperfusion) was used to assess significant differences between nonischemic controls and the two groups of ischemic hearts. A comparison of the means of each group within each time interval during the last 2 hours of perfusion was performed with Tukey's studentized range test. Student's t-test for paired observations was used to evaluate significant differences between baseline values (mean of two recordings obtained at 30 and 45 minutes of perfusion) and values obtained during subsequent perfusion within each group of hearts. Student's /-test and x 2 analysis were used to assess differences in total water content, and the former statistical test also was used in Tables 1 and 3 .
Results
Heart Weight, Flow Rate, and Water Content Heart weight (~1.0 g dry weight) and perfusate flow rate (~23 ml/min per g dry weight) did not differ significantly between the control and ischemic groups of hearts. The water content of hearts perfused continuously for 5 hours averaged 5.5 ± 0.3 ml/g dry weight (mean ± SD; Fig. 1 ). The water content was reduced to 4.2 ± 0.2 ml/g dry weight when control hearts were treated with 3000 U/ml hyaluronidase during a 10-minute no-flow period after the initial 60 minutes of perfusion. Untreated hearts reperfused for 3.5 hours following 30 minutes of ischemia contained 18% more water than control hearts (t = 4.03, P < 0.005) and 24% more water than hyaluronidase-rreated, ischemic hearts (t = 4.06, P < 0.005). Although the mean water content of the hyaluronidase-rreated ischemic group was only 5% less than that of untreated controls, the variance was over 2X that of controls. Thus, five hyaluronidase-treated ischemic hearts had appreciably less water, whereas two had more water than the untreated control group, so that the x 2 for the difference between the two groups was statistically significant (x 2 = 5.00, P < 0.025).
Interstitial and Intracellular Fluid Volumes
After 5 hours of perfusion, the interstitial fluid volume of untreated control hearts averaged 1.76 ± 0.76 ml/g dry weight, whereas that of hyaluronidase-treated control hearts averaged 0.95 ± 0.65 ml/ g dry weight (Table 1) . Reperfusion for 3.5 hours following 30 minutes of no flow was associated with a 90% increase in the interstitial fluid volume (t = 2.97, P < 0.025), compared to untreated controls, while hyaluronidase treatment during no flow completely blocked this increase. Intracellular water, which averaged 2.40 ± 0.84 ml/g dry weight at the end of untreated control perfusions, was decreased slightly in the untreated ischemic hearts; this difference, however, was not statistically significant. Hyaluronidase had no effect on the intracellular water content of control or ischemic hearts.
Physiological Pressure Data
Perfusion pressure ( Fig. 2 ) was adjusted to ~43 mm Hg at the beginning of each experiment and, in controls, remained constant for the entire duration of perfusion. No significant differences were evident in baseline perfusion pressures of either group of ischemic hearts compared to controls. After 1 minute of reperfusion following 30 minutes of global, noflow ischemia, perfusion pressure was significantly lower than baseline in both groups of ischemic hearts, hi untreated ischemic hearts, perfusion pressure was 40% above baseline values by 1 hour and 53% above baseline by 3 hours of reperfusion (t = 4.32, P < 0.005; compared to baseline). Instillation of 1000 U/ml hyaluronidase into the coronary vasculature at the onset and for the duration of no-flow injury partially blocked the perfusion pressure increases during reflow (pressure recordings reached levels 34% above baseline after 3 hours of reperfusion). A repeated-measures analysis of variance test indicated that during the last 2 hours of perfusion differences in perfusion pressure between each group of hearts were highly significant (P < 0.0001). Results are expressed as mean ± SD; n •= number of rabbit hearts evaluated.
• Calculated by subtracting baseline estimates of vascular volume obtained from external-detection data from VEDTA (Eq. 1) obtained from 57 Co-EDTA equilibrium data at the end of the perfusion. f Calculated as total water content determined gravimetricaUy at the end of the perfusion minus VEDTA.
J ml/g dry weight.
§ Student's (-test (compared to nonischemic control perfusions). P < 0.025. |j Student's (-test (compared to untreated ischemic perfusions). P < 0.025. A comparison of the means of each group at each time interval during the last 2 hours of perfusion indicated that only perfusion pressure of untreated ischemic hearts differed significantly from that of controls (Tukey's Studentized range test, P < 0.05). LVEDP ( Fig. 3) , adjusted during baseline to ~5 mm Hg by filling the left ventricle balloon with KH buffer, remained constant in controls for the entire duration of perfusion. After 30 minutes of no-flow ischemia, LVEDP had increased to levels 4.6X above baseline in the untreated hearts and 5.5X above baseline in hyaluronidase-rreated hearts. Differences between the two ischemic groups were not statistically significant at any time during no flow or reperfusion. During reperfusion, LVEDP decreased in both groups of ischemic hearts, remaining significantly elevated above control values during the last FIGURE 4. Left ventricular developed pressure for nonischemic controls and hearts subjected to 30 minutes of no-flow ischemia (mm Hg; mean ± SSM). Developed pressure was calculated as end-systolic pressure minus LVEDP and was used as an index of maximal heart contraction. Solid circles denote nonischemic controls (n = 6); solid triangles, untreated hearts subjected to 30 minutes of no-flow ischemia (n = 7); open triangles, ischemic hearts treated with 1000 U/ ml hyaluronidase during no flow (n •» 9).
2 hours of reperfusion when assessed with a repeated-measures analysis of variance test (P < 0.0001). Values at each time interval did not differ from controls when assessed with Tukey's Studentized range test. Left ventricular developed pressure (Fig. 4) averaged 80 mm Hg during baseline, and in control perfusions remained constant. In both groups of ischemic hearts, developed pressure dropped promptly to 0 during no-flow ischemia; after 60 minutes of reperfusion, developed pressure had recovered to 95% of baseline in untreated hearts and 94% of baseline in hyaluronidase-treated hearts. Although differences between these groups were small and not significant when assessed with Tukey's Studentized range test, they were significant by the repeated-measures analysis of variance test (P< 0.0001).
The maximum rate of left ventricular pressure development, +dP/dt, for controls and for hearts subjected to ischemia and reperfusion is shown in Figure 5 . Maximum +dP/dt averaged 1350 mm Hg/ sec during baseline in controls and, except for a slight increase evident by 3 hours of perfusion, remained constant for 5 hours. In both groups of ischemic hearts, +dP/dt recovered ~50% by 10 minutes of reperfusion and returned to baseline and control values by 30 minutes of reperfusion. All three groups were similar to one another during the last 2 hours of perfusion (Tukey's Studentized range test). Figure 6 shows a representative series of timeactivity curves generated after a bolus injection of 125 I-BSA into the proximal aorta every 30 minutes during 5 hours of perfusion. The maximum-likelihood estimate of the intensity function, r(t), was plotted as a solid curve for each run. The data were normalized to the peak count rate, r 0 , and plotted for times during which the count rate decreased to 0.01% of the peak value. The curves exhibited peak (Fig.  6a) , the y-intercepts, A 2 , of the tails of the washout curves increased gradually with increasing duration of perfusion whereas the slopes, az, of the same portion of the curves remained relatively constant. During reperfusion after 30 minutes of no-flow ischemia in untreated (Fig. 6b) and hyaluronidasetreated (Fig. 6c) hearts, the y-intercepts of the tails of the washout curves increased progressively and the slopes became much steeper relative to baseline (and controls). The slope of the initial portion of the washout curve, a ir decreased slightly, but similarly, in both groups of ischemic hearts during reperfusion.
12J I-BSA Time-Activity Curves
Compartmental-Model Analysis of Radiolabeled Albumin External-Detection Data
Tracer turnover-rate constants (km, k ]2 , k 2 i) and estimates of 125 I-BSA vascular into extravascular space clearance (F 2 i) and mean-transit time (tesA) are shown in Table 2 for 5-hour control perfusions and for untreated and hyaluronidase-treated hearts subjected to 30 minutes of no-flow ischemia and reperfusion. Baseline values for the rate constant koi (clearance of tracer from the coronary vasculature) were similar for all groups of hearts and remained constant throughout the perfusion interval in nonischemic control experiments. Significant decreases in koi compared to controls were observed after 2 hours of reperfusion in the hyaluronidase-treated ischemic hearts and after 3 hours of reflow in the untreated ischemic hearts (Tukey's Studentized range test, P < 0.05). The turnover-rate constants k ]2 (from extravascular into vascular space) and k 2 i (from vascular into extravascular space) were similar for nonischemic controls and both groups of ischemic hearts during baseline. Significant increases in kj 2 compared to control values were observed in hyaluronidase-treated ischemic hearts during the last 2 hours of reperfusion, while increases were significant only at the end of reflow in the untreated ischemic hearts. Whereas k 2 i increased significantly relative to baseline during the course of the perfusion in nonischemic controls (t = 3.25, P < 0.025), much larger increases were observed during reflow in both groups of ischemic hearts (t = 7.96, P < 0.001 and t = 6.68, P < 0.001 for untreated and hyaluronidase-treated hearts, respectively, compared to baseline). A repeated-measures analysis of variance test (P < 0.0001) and Tukey's Studentized range test (P < 0.05) indicated that k 2 , of both groups of ischemic hearts differed significantly from controls but not from each other during the last 2 hours of reperfusion.
Albumin vascular into extravascular space clearance, F 2 i, averaged 0.0033 ml/sec per g dry weight during baseline and increased 2.5X during 5 hours of continuous perfusion. Although this was a significant increase over baseline (t = 2.85, P < 0.05), it was much smaller than the 5.6-fold increase ob- Results are expressed as mean ± SD; n = number of rabbit hearts evaluated for each time interval. * jil/sec per g dry weight; calculated from Equation 11 using baseline estimates of Vi. f Baseline denotes an average of two recordings during the first hour of perfusion. Parentheses indicate duration of reperfusion following 30 minutes of no-flow ischemia.
* P < 0.05 (compared to nonischemic control perfusions) and | P < 0.05 (compared to untreated ischemic perfusions), by Tukey's Studentized range test.
served by the end of reperfusion of untreated ischemic hearts (t = 5.81, P < 0.005). Hyaluronidase was without effect on this parameter; a repeatedmeasures analysis of variance test using albumin clearance data collected during the last 2 hours of reperfusion confirmed that both groups of ischemic hearts differed significantly from controls (P < 0.0001) but not from each other (P < 0.1).
Baseline mean-transit times of radiolabeled albumin (tesA) for all groups of hearts were similar (6.7-7.6 seconds), and in nonischemic controls, increased gradually as a function of the duration of perfusion by -50% after 5 hours (t = 4.62, P < 0.01; compared to baseline). During reperfusion after ischemia, \ BS A increased much more rapidly in the untreated hearts and by 2 hours of reperfusion, was 2x that of controls (Tukey's studentized range test, P < 0.05). tesA of hyaluronidase-treated hearts also increased more rapidly than in nonischemic controls, but the increase was not as great as that of untreated ischemic hearts, and after 3 hours of reperfusion, differed significantly from that of the latter group (Tukey's Studentized range test, P < 0.05). Assessment of t BSA during the last 2 hours of perfusion with a repeated-measures analysis of variance test indicated that differences between each group of hearts were highly significant (P < 0.0001).
Albumin Diffusive-and Convective-Transport Parameters
Estimates of diffusive-(PS, Equation 9) and convective-(0; Eq. 10) transport parameters for 125 I- Results are expressed as mean ± SD; n -number of rabbit hearts evaluated.
* Diffusive-and convective-transport parameters were calculated from Equations 9 and 10 utilizing baseline estimates of vascular volume derived from two-compartment model data fitting and estimates of interstitial fluid volume obtained by subtraction of vascular volume from the 57 Co-EDTA space determined at the end of the perfusion.
* fil/sec per g dry weight. *P < 0.05; § P < 0.005; | P < 0.001, by Student's /-test (compared to nonischemic controls).
BSA based on baseline estimates of vascular volume obtained from external detection and interstitial fluid volume obtained from S7 Co-EDTA equilibration data at the termination of selected experiments are shown in Table 3 . After 5 hours of continuous perfusion, permeation of the vasculature by 125 I-BSA is accounted for primarily by diffusive transport (91%). After 3.5 hours of reperfusion following 30 minutes of ischemia, PS was 4.0X that of nonischemic controls and ultrafiltration accounted for 15% of total albumin transport. In hyaluronidasetreated ischemic hearts, PS was still 3.2X that of nonischemic controls and not different from that of the untreated ischemic group; ultrafiltration accounted for 23% of total albumin transport, but this was not statistically different from that of untreated ischemic hearts.
Discussion
These experiments confirm our previous observations that reperfusion of isolated hearts after 30 minutes of no-flow ischemia is associated with marked increases in total water content, extracellular fluid volume, vascular resistance, and vascular permeation by 125 I-BSA, while indices of left ventricular function, including developed pressure and maximum +dP/dt, rapidly return to preischemic baseline levels (Tilton et al., 1983 (Tilton et al., , 1985 . The significant increases in extracellular water and in albumin permeation across endothelium during reperfusion indicate that damage to vascular endothelium is an important, early consequence of ischemia and reperfusion, with functional sequelae that persist despite recovery of left ventricular function. Although the observations that hyaluronidase decreased the water content of ischemic tissue and partially blocked the vascular-resistance increases are consistent with previous reports (de Oliveira and Levy, 1960; Rovetto, 1977; Overholser and Harris, 1981; Sunnergren and Rovetto, 1983) , the finding that hyaluronidase does not prevent ischemia-reperfusion-induced increases in albumin permeation is a new one which suggests that this enzyme does not protect endothelial cells from ischemic injury.
The possibility that hyaluronidase may have increased albumin leakage was ruled out in separate control experiments in which the enzyme was instilled at a concentration 3x that used in the earlier (30-minute no-flow) preparations for 10 minutes of no flow (n = 6). Additional controls (n = 3) were subjected to 10 minutes of no flow without hyaluronidase, and in both groups of hearts, perfusion pressure, LVEDP, left ventricular developed pressure, and +dP/dt rapidly returned to baseline values during reperfusion. Although 3000 U/ml hyaluronidase significantly decreased the water content of the treated hearts compared to untreated controls (Fig. 1) , it had no effect on albumin permeation, which was similar for both groups of hearts after 5 hours of perfusion (unpublished observations).
Circulation Research/Vol. 56, No. 6, June 1985 These results indicate that the chiomatographically purified and dialyzed hyaluronidase used in these experiments did not alter coronary vascular permeability to albumin. This finding is consistent with that of Houck and Chang (1979) , who reported that the increased vascular permeability sometimes associated with administration of hyaluronidase is due to a contaminant of the enzyme preparation and not to the enzyme itself.
Baseline estimates of k 2] in this study predict very rapid albumin equilibration between the intravascular and extra vascular compartments. Although the observation that albumin permeation of coronary vessels is higher in these experiments than in vivo is consistent with previous reports (Sutherland and Young, 1966; Young, 1968) , the increased k 21 does not necessarily imply vascular damage, but may be accounted for by shifts in pressure gradients across vessel walls when blood is replaced with a lowviscosity asanguineous perfusate.
Although pressure data remained constant, estimates of albumin permeation, F 2] , and the meantransit time of radiolabeled albumin increased significantly in hearts perfused continuously for 5 hours. Since perfusate flow rate and intravascular clearance of radiolabeled albumin (koi) remained constant, increases in the vascular into extravascular space rate constant (k 2 i) for radiolabeled albumin accounted for the increases in F 2 i (Eqs. 6 and 11). This increase could result from: (1) fluid shear stress damage (focal or diffuse) to endothelium induced by high perfusate flow rates, and/or (2) changes in pressure gradients across vessel walls (see discussion under 'Myocardial Edema*) resulting in increased ultrafiltration of albumin and water without any vascular damage or change in vascular porosity per se. In view of the absence of ultrastructural evidence of endothelial damage, we tend to favor the latter explanation. The finding that k J2 does not increase in parallel with k 2 , is consistent with the observation that V 2 increases during the course of these perfusions, whereas Vi remains constant.
Baseline estimates of vascular volume (Eq. 6) averaged ~1.0 ml/g dry weight in these experiments. We have reported previously that the weight of vascular fluid in isolated hearts was 15% of total heart weight (Tilton et al., 1983J . This value, which was calculated using baseline Vj estimates of ~0.8 ml/g dry weight, is consistent with the high vascularity of cardiac tissue and is in good agreement with data by Gonzalez et al. (1980) . The slightly larger estimates of V] in this study probably are accounted for by the ~10% increase in perfusion pressure and flow rates, which would tend to dilate the vasculature. The fact that estimates of vascular volume obtained by external detection are larger, in general, than those based on gravimetric analysis is probably explained by the unavoidable loss of blood from the larger coronary vessels with the latter technique. This interpretation is supported by the finding that I-BSA content of the heart is monitored by external detection, almost one half of the activity in the heart is lost within seconds of turning off the perfusion pump.
The significant increase in tesA during control perfusions may be due to an increase in the albumin volume of distribution (vascular and/or exrravascular, the latter of which was increased) and/or to an increase in albumin ultrafiltration across coronary endothelium. The possibility that developing regions of low flow contribute to the prolonged mean-transit time of 12S I-BSA in control perfusions can be virtually excluded on the basis of the observation that koi (the fractional rate of tracer clearance from the coronary vasculature) and a u the slope of the initial portion of the washout curve, remained constant for 5 hours.
Myocardial Edema
We elected to use asanguineous Krebs-Henseleit buffer to perfuse isolated rabbit hearts for convenience and to avoid difficulties associated with aggregation of cellular elements and/or hemolysis during 5 hours of perfusion. Although this results in significant increases in the myocardial water content of nonischemic control hearts relative to nonperfused hearts, evidence discussed below indicates that the increased water is localized primarily to the cardiac interstitium, and the increased extracellular fluid does not interfere with our ability to demonstrate marked increases in vascular leakage of albumin and in water content of the heart during reperfusion after ischemia. The increased water content may simply be the consequence of a downstream shift in the distribution of pressure gradients across vessel walls (due to the low perfusate viscosity), resulting in an increase in convective transport of water and small molecular weight solutes. This interpretation is consistent with the virtually normal ulrrastructural appearance of endothelium of these hearts. It is noteworthy that maximum +dP/dt remained constant for the entire duration of perfusion, suggesting that the extracellular edema did not compromise myocardial contractility, and that the tissue was adequately oxygenated. In light of the fact that this is a "low-work" heart preparation, it might be anticipated that the deleterious effects of ischemia and reperfusion would be even more severe in working heart preparations or in vivo.
Several lines of evidence indicate that, under the conditions of these experiments, the increased water content of ischemic-reperfused hearts is localized primarily in the interstitium. First, 10-minute equilibration data obtained at the end of selected experiments indicated that the 57 Co-EDTA volume of distribution was increased markedly after ischemia and reperfusion in untreated hearts, and that this increased volume could be accounted for entirely by the increase in total water content without any change in inrracellular water. Second, the decrease 847 in total tissue water associated with hyaluronidase treatment during no flow was entirely accounted for by the decrease in interstitial fluid volume without any changes in the estimates of vascular and intracellular volumes. Third, as discussed above, the significant increase in tssA in the untreated ischemic hearts is attributable to an increase in the albumin volume of distribution (vascular and/or extravascular, both of which were increased) and to an increase in albumin ultrafiltration across coronary endothelium. Since hyaluronidase treatment did not affect diffusive or convective transport of albumin (Table  3) , the reduction in TBSA observed after 3 hours of reflow in hyaluronidase-treated ischemic hearts (compared to untreated ischemic hearts) must be attributed to a decrease in the albumin volume of distribution. This interpretation is consistent with the marked decrease in interstitial fluid volume shown in Table 1 .
The increased IBSA during reperfusion after ischemia may also be accounted for in part by the development of flow heterogeneity. This interpretation is supported by the observation that koi, the rate of clearance of radiolabeled tracer from the coronary vasculature, was decreased by ~40% in both groups of ischemic hearts. It is of interest, however, that decreases in koi were similar in the hyaluronidase-treated and untreated ischemic hearts, even though IBSA of the former was significantly less than that of the latter at the end of the experiment.
Vascular Hemodynamic Changes
Although vascular hemodynamic changes, including increased vascular resistance and increased flow heterogeneity (leading ultimately to regions of no flow) during and following ischemia have long been recognized, the underlying pathophysiological mechanisms{s) responsible for these changes has not been fully elucidated. The hemodynamic changes may result from an increase in the inrracellular water content of ischemic tissue. Endothelial cell swelling (Kloner et al., 1974; Armiger and Gavin, 1975) and capillary collapse and/or compression secondary to myocardial cell swelling (Hauschild et al., 1970) have been suggested as possible explanations for the failure of vascular reperfusion following ischemia. The possibility that the increased volume of extracellular fluid in the untreated, ischemic-reperfused hearts compressed vessels, producing regions of no reflow, appears unlikely in view of separate experiments in which colloidal carbon (dialyzed, filtered through 1.2-jtm Acrodisc filters immediately before use) was infused during the terminal 15 seconds (unpublished observations). Hearts were removed from the perfusion chamber, fixed in 10% formalin, sectioned into ~10 transmural pieces, and examined for areas of myocardium that were not labeled with carbon, hi continuously perfused (n = 1), as well as in ischemic-reperfused hearts (n = 3), myocardium was uniformly darkened, including subendocardial regions and papillary muscles. Although this technique cannot demonstrate regions of low flow, these results do suggest that significant areas of no flow did not develop during reperfusion after ischemia in this experimental model. These findings, together with the observation that myocardial contractility recovered completely during reperfusion, are consistent with the observations that 30 minutes of ischemia are minimum for the development of no reflow in the intact dog model (Kloner et al., 1974) , as well as in isolated, buffer-perfused rat hearts (Humphrey et al., 1980 (Humphrey et al., , 1984 . Furthermore, in the absence of blood cells in these experiments, complete collapse and/or compression of vessels by extravascular fluid would be necessary to produce regions of no flow, and this seems unlikely in view of the constant flow conditions employed.
Reduced myocardial perfusion during reflow after ischemia also has been attributed to intramyocardial tension generated by ischemic contracture of myocytes (Hearse et al., 1977; Gavin et al., 1978; Alanen et al., 1980; Humphrey et al., 1980) . It is noteworthy, however, that the experimental protocol in those studies differed significantly from our experiments, in that the hearts were perfused under conditions of constant pressure rather than constant flow, reperfusion was absent or very brief (only a few seconds), and/or myocyte contractile function was markedly impaired. The observations in our experiments that koi was not decreased at 1 minute reflow when LVEDP was increased maximally, and that during subsequent reperfusion, LVEDP decreased while the rate of intravascular clearance of tracer was prolonged suggest that the hemodynamic changes observed during reflow were independent of myocyte contracture. Furthermore, in view of evidence that placement of an isovolumic balloon in the left ventricle reduces no reflow associated with ischemic contracture (Humphrey et al., 1981) , the isovolumic balloon in the left ventricle of our isolated heart preparations should minimize the development of such perfusion defects in our experiments. In any case, our observations that indices of myocyte function, including LVEDP, developed pressure, maximum +dP/dt, and intracellular water content returned to control levels during reperfusion, while indices of vascular function deteriorated, suggest that ischemic injury to the vasculature is independent of, and precedes that to, myocytes under the conditions of our experiments.
Intracellular water may indeed be increased early during reperfusion following brief periods of ischemia (Leaf, 1973; Whalen et al., 1974) and/or after ischemic intervals that result in irreversible membrane damage during reflow. However, the observations in our experiments that intracellular water content was not increased after 3.5 hours of reperfusion (Table 1) and that left ventricular function had recovered to baseline and control levels by 1 hour of reflow, suggest that any increase in intraCirculation Research/Vol. 56, No. 6, June 1985 cellular water that might have occurred early in the course of reperfusion at a time when contractile function was still impaired was not substantial or was subsequently reversed during 3.5 hours of reperfusion. Although the observation that intracellular water content of ischemic hearts was not decreased suggests that little, if any, 57 Co-EDTA accessed myocytes, we cannot rule out the possibility that cell swelling of viable myocytes, which exclude 57 Co-EDTA, is balanced by "Co-EDTA penetration of a small number of lethally injured myocytes, resulting in no net change in intracellular volume.
It is of interest that estimates of vascular volume (Eq. 6) increased ~60% during reperfusion in both groups of ischemic hearts in the face of significant increases in perfusion pressure. Since flow rate was held constant in these experiments, dilation of the coronary vasculature proximal to sites of constriction or increased vascular resistance could account for the increase in vascular volume. This interpretation is consistent with evidence that most of the vascular volume is contained within large vessels (Green, 1950) and that 4 ^M diltiazem prevents increases in both perfusion pressure and vascular volume (Tilton et al., 1985) . Increased estimates of vascular volume observed during reflow could be accounted for by prolonged washout of radiolabeled tracer from the coronary vasculature and/or increased porosity of the vasculature, rather than an actual anatomical increase in vascular volume. For this reason and the fact that the possibility of flow heterogeneity after ischemia cannot be excluded, only baseline estimates of V] were used in calculations of albumin permeation (Eq. 11) during reperfusion.
The possibility that increases in vascular resistance in the ischemic-reperfused hearts accounted for the increases in k 2] was excluded on the basis of several different lines of evidence. First, only one fifth of the total albumin transport in ischemic-reperfused hearts was attributable to ultrafiltration, which would be affected by changes in perfusion pressure. The remainder was accounted for by diffusion, which could not be influenced by pressure changes. Second, in a separate study (Tilton et al., 1985) , 0.4 HM diltiazem decreased by one half the perfusion pressure increases observed during reflow after 30 minutes of ischemia, but did not reduce albumin permeation of the vasculature. Third, in a separate series of unpublished experiments in which aortic perfusion pressure was maintained at baseline levels (by decreasing the buffer flow rate) during reperfusion after 30 minutes of no-flow ischemia, albumin permeation was still significantly elevated over nonischemic controls. Only the difference in k 2 i between these constant pressure experiments (~4-fold increase) and the constant flow experiments (~5-fold increase) can be attributed to convective albumin transport.
Other Effects of Hyaluronidase
Since hyaluronidase was present within myocardium only during the no-flow period, its effect on tissue-water content probably is not mediated by an intravascular osmotic effect during reperfusion. Likewise, the observation that hyaluronidase decreased the tissue-water content of controls (in which the effects of the 10-minute ischemic incubation with hyaluronidase were completely reversible) indicates that hyaluronidase effects are not restricted to edema resulting from ischemia-reperfusion injury. These results are consistent with the report of Sunnergren and Rovetto (1983) , who have shown that hyaluronidase significantly reduces the tissue-water content of buffer-perfused rat hearts, and that the reduction in water content could be accounted for by changes in extracellular-water content with no change in intracellular-water content.
Since there is no experimental evidence to suggest that hyaluronidase acts intracellularly, the ability of this enzyme to block increases in interstitial edema during reperfusion must be due, at least in part, to depolymerization of the large mucopolysaccharide matrix of the interstitium (Wolf et al., 1980) . This would decrease the mass of extracellular matrix and increase the fluidity of the residual matrix relative to its normal gel-like consistency. These changes could render the interstitial matrix more compliant, which would tend to reduce vascular resistance and also facilitate permeation of the matrix by solutes. This interpretation is consistent with the observations of de Oliveira and Levy (1960) , and further suggests a possible mechanism to account for the observed increases in collateral blood flow (Askenazi et al., 1977; Rovetto, 1977) . These observations and interpretations also suggest that the increased vascular resistance observed during reflow cannot be attributed entirely to increased tissue edema, but must be due, at least in part, to vasoconstriction.
In conclusion, these findings indicate that hyaluronidase does not prevent ischemia-reperfusioninduced increases in albumin permeation of the coronary vasculature, and suggest that its protective effect on ischemic myocardium is mediated, instead, by reducing interstitial edema and vascular resistance.
